X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
female (9) 9
humans (9) 9
male (9) 9
middle aged (9) 9
hematology (8) 8
adult (7) 7
aged (7) 7
multiple myeloma (7) 7
multiple myeloma - drug therapy (6) 6
article (5) 5
bortezomib (5) 5
care and treatment (5) 5
dexamethasone (5) 5
disease-free survival (5) 5
survival (5) 5
transplantation (5) 5
treatment outcome (5) 5
antineoplastic agents - therapeutic use (4) 4
multiple myeloma - therapy (4) 4
thalidomide - analogs & derivatives (4) 4
abridged index medicus (3) 3
analysis (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
autografts (3) 3
clinical medicine (3) 3
diagnosed multiple-myeloma (3) 3
hematopoietic stem cell transplantation (3) 3
intergroupe francophone (3) 3
klinisk medicin (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
multiple myeloma - genetics (3) 3
stem cells (3) 3
survival analysis (3) 3
thalidomide - therapeutic use (3) 3
therapy (3) 3
transplantation, autologous (3) 3
adolescent (2) 2
antineoplastic agents - administration & dosage (2) 2
basic medicine (2) 2
cancer (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
cd38 antigen (2) 2
daratumumab (2) 2
double-blind method (2) 2
drug therapy (2) 2
drugs (2) 2
follow-up studies (2) 2
hematologi (2) 2
immunologi inom det medicinska området (2) 2
immunology in the medical area (2) 2
immunomodulation (2) 2
kaplan-meier estimate (2) 2
lenalidomide (2) 2
medical research (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
medicinska och farmaceutiska grundvetenskaper (2) 2
molecular classification (2) 2
monoclonal antibodies (2) 2
multiple myeloma - mortality (2) 2
myeloma (2) 2
oncology (2) 2
patient outcomes (2) 2
prognosis (2) 2
prospective studies (2) 2
proteasome inhibitors (2) 2
refractory materials (2) 2
risk (2) 2
stem cell transplantation (2) 2
usage (2) 2
young adult (2) 2
14) translocation (1) 1
acute lymphoblastic-leukemia (1) 1
age factors (1) 1
aged patients (1) 1
aged, 80 and over (1) 1
al amyloidosis (1) 1
alkylation (1) 1
amyloidosis - drug therapy (1) 1
amyloidosis - immunology (1) 1
amyloidosis - mortality (1) 1
amyloidosis - surgery (1) 1
anemia (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
asthma (1) 1
autologous transplantation (1) 1
benzimidazoles - administration & dosage (1) 1
benzimidazoles - adverse effects (1) 1
benzimidazoles - therapeutic use (1) 1
biological products (1) 1
bone5 (1) 1
brief report (1) 1
canada (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4653 - 4653
Introduction: The gut microbiome is an important mediator of the host immune system, and studies in allogeneic transplantation demonstrate that loss of... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2036 - 2036
Patients who develop therapy-related myelodysplastic syndromes (t-MDSs) or acute myeloid leukemia (t-AML) following prior chemotherapy or an autologous... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4480 - 4480
Abstract Background and Aims. Despite the fact that the myeloma mutational landscape was elucidated several years ago, there are yet no approved precision... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5470 - 5470
Introduction: Chronic lymphocytic leukemia (CLL) is incurable with standard therapy. With first-line chemotherapy, some patients (pts) may achieve durable... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3088 - 3088
Background: Despite unprecedented response rates associated with "novel agents", HDT/AHCT is a therapeutic mainstay for transplant eligible patients with MM.... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1006 - 1006
Abstract Multiple myeloma (MM) is characterized by clonal expansion of malignant plasma cells (PCs) and aberrant production of monoclonal immunoglobulin... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2107 - 2107
Abstract Introduction: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for myelodysplastic syndrome (MDS) and... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1210 - 1210
Regulated proteolysis of the tolerogenic matrix proteoglycan versican (VCAN) through the actions of ADAMTS-proteases, is associated with enhanced CD8+... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3157 - 3157
Introduction: Selinexor is a novel, first-in-class selective inhibitor of nuclear export (SINE), which blocks XPO1, forcing the nuclear retention and... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3165 - 3165
Introduction: The nuclear export protein Exportin 1 (XPO1) is overexpressed in a wide variety of cancers including multiple myeloma. Selinexor is a novel,... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4485 - 4485
Abstract Background: I-131-CLR1404 is a novel radioiodinated therapeutic that exploits the selective uptake and retention of phospholipid ethers (PLEs) by... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4194 - 4194
Abstract BACKGROUND: Agent Orange (AO) is an herbicide that was previously used by the United States armed forces during the Vietnam conflict during the years... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2114 - 2114
Abstract The University of Wisconsin Chemotherapy Council (UWCC) monitors the uniformity and appropriateness of chemotherapy administration at the University... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3125 - 3125
Introduction: Proteasome inhibitors (PI), immunomodulatory agents (IMiDs) and the CD38 monoclonal antibody daratumumab (dara) have transformed the management... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e15082 - e15082
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4209 - 4209
Abstract Background:Multiple Myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal, mutated plasma cells, which ultimately... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3174 - 3174
Abstract Background: Immunomodulatory agents and proteasome inhibitors have significantly improved outcomes in the management of patients with multiple myeloma... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1770 - 1781
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.